Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Switzerland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20071
20081
20103
20121
20132
20161
20182
20191
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed7
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Pfizer2
Sanofi2
Amgen1
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Cantonal Hospital of St. Gallen1
ECRI bv1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases21
Stroke8
Myocardial Infarction7
Hyperlipidemias3
Hypertension3
Atrial Fibrillation2
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Heart Failure2
Heart Valve Diseases2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.